Concepedia

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)

Ronald N. Jones, Matthew A.T. Croco, Michael A. Pfaller, Mondell L. Beach, Kari C. Kugler

Clinical Microbiology and Infection · 1999 · 22 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Mary Jane Ferraro · 2000 · 16.9K citations

, , +5

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Michael A. Pfaller, Ronald N. Jones, Gary V. Doern et al. · Antimicrobial Agents and Chemotherapy · 1998 · 547 citations · Full text

Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]

A. Bauernfeind · Journal of Antimicrobial Chemotherapy · 1997 · 302 citations · Full text

, , +20

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

M Nakashima, Toshihiko Uematsu, Kazuhiro Kosuge et al. · Antimicrobial Agents and Chemotherapy · 1995 · 160 citations · Full text

, , +10

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

B B Gooding, Ronald N. Jones · Antimicrobial Agents and Chemotherapy · 1993 · 122 citations · Full text